Optimedica
- Add other possible names for this topic
OptiMedica® Corporation is a medical device company dedicated to working with ophthalmologists to evolve standards of care which provide significant benefits to both physicians and patients. Located in Santa Clara California, the company was founded in January 2004 to develop a radically new technology for the treatment of ocular disease. Initially developed at Stanford University, and exclusively licensed to the OptiMedica Corporation, the PASCAL® Method of Photocoagulation is used to treat a variety of retinal conditions including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive disease. The PASCAL Photocoagulator provides significantly improved performance for the physician and an enhanced therapeutic experience for the patient.
Business
| Date founded |
- Jan 2004
| Place founded |
| Headquarters |
|
street address
|
city/town
|
state/province/region
|
postal code
|
country
|
|---|---|---|---|---|
|
| |||
| Legal structure |
| Industry |
| Revenue |
| Operating income |
| Market capitalization |
| Founders |
| Net income |
| Board members |
| Major shareholders |
| Advisors |
| Number of employees |
| Ticker symbol |
| Slogan |
| Previous names |
| Parent company |
| Subsidiary companies |
| Spun off from |
| Spin offs |
| Acquired by |
| Companies acquired |
| Involved in merger |
| Product of merger |
| Business Locations |
| Divisions |
| Employees and other personnel |
|
person
|
title
|
|---|---|
| Gallery | add an image | edit gallery |
Edit Weblinks
Recent Discussions about Optimedica
There are no conversations on this topic. Would you like to start one?
Start the Discussion